Temoporfin – Interleukin Related interleukin-related.com

Product Name :
Temoporfin

Search keywords :
Temoporfin

drugId :
null

Target Vo:
Reactive oxygen species

Target Vo Short Name :
Reactive oxygen species

Moa_Name:
Reactive oxygen species stimulants

First Approval Country :
EU

First Approval Date Filter:
2001

Origin Company_Name :
Biolitec

Active Company_Name :
Biolitec Pharma Ltd

Active Indication_Name:
Squamous Cell Carcinoma of Head and Neck

In Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
MMP9 Antibody (YA285)
BTK Antibody (YA816)
TNFRSF10B Antibody (YA660): TNFRSF10B Antibody (YA660) is a non-conjugated and Mouse origined monoclonal antibody about 48 kDa, targeting to TNFRSF10B (7F4). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts